Up-regulation of neurofilament light chains is associated with diminished immunoreactivities for MAP2 and tau after ischemic stroke in rodents and in a human case

Journal of Chemical Neuroanatomy

Volumn 78, Issue , 2016, Pages 140-148

  Härtig, Wolfgang ^a   Krueger, Martin ^a   Hofmann, Sarah ^a   Preißler, Hartmut ^a   Märkel, Martin ^a   Frydrychowicz, Clara ^a   Mueller, Wolf C ^a   Bechmann, Ingo ^a   Michalski, Dominik ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cytoskeleton; Ischemic brain; Microtubule; Stroke; Tau; Triple fluorescence labeling

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT LIGHT CHAIN; NEUROFILAMENT PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; MICROTUBULE ASSOCIATED PROTEIN; NEUROFILAMENT PROTEIN L;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MIDDLE AGED; MOUSE; NEOCORTEX; NONHUMAN; PATHOGENESIS; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PYRAMIDAL NERVE CELL; RAT; UPREGULATION; ANIMAL; BRAIN; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; METABOLISM; WISTAR RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEUROFILAMENT PROTEINS; RATS; RATS, WISTAR; STROKE; TAU PROTEINS; UP-REGULATION;

EID: 84988484689     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2016.09.004     Document Type: Article

References (50)

1. Acarín, L., Vela, J.M., González, B., Castellano, B., Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J. Histochem. Cytochem. 42 (1994), 1033–1041.
2. Aronowski, J., Cho, C.H., Strong, R., Grotta, J.C., Neurofilament proteolysis after focal ischemia: when do cells die after experimental stroke?. J. Cereb. Blood Flow Metab. 19 (1999), 652–660.
3. Berkhemer, O.A., Fransen, P.S., Beumer, D., van den Berg, L.A., Lingsma, H.F., Yoo, A.J., et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372 (2015), 11–20.
4. Block, J., Schroeder, V., Pawelczyk, P., Willenbacher, N., Köster, S., Physical properties of cytoplasmic intermediate filaments. Biochim. Biophys. Acta 1853 (2015), 3053–3064.
5. Braeuninger, S., Kleinschnitz, C., Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp. Transl. Stroke Med., 1, 2009, 8.
6. Dawson, D.A., Hallenbeck, J.M., Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J. Cereb. Blood Flow Metab. 16 (1996), 170–174.
7. Dirks, M., Niessen, L.W., van Wijngaarden, J.D., Koudstaal, P.J., Franke, C.L., van Oostenbrugge, R.J., et al. Promoting thrombolysis in acute ischemic stroke. Stroke 42 (2011), 1325–1330.
8. Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999), 391–397.
9. Dirnagl, U., Hakim, A., Macleod, M., Fisher, M., Howells, D., Alan, S.M., et al. A concerted appeal for international cooperation in preclinical stroke research. Stroke 44 (2013), 1754–1760.
10. Donnan, G.A., Fisher, M., Macleod, M., Davis, S.M., Stroke. Lancet 371 (2008), 1612–1623.
11. Durukan, A., Tatlisumak, T., Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 87 (2007), 179–197.
12. Fisher, M., Feuerstein, G., Howells, D.W., Hurn, P.D., Kent, T.A., Savitz, S.I., Lo, E.H., STAIR Group, Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40 (2009), 2244–2250.
13. Godsel, L.M., Hobbs, R.P., Green, K.J., Intermediate filament assembly: dynamics to disease. Trends Cell Biol. 18 (2007), 28–37.
14. Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., et al. Thrombolysis with alteplase 3 to 4: 5 hours after acute ischemic stroke. N. Engl. J. Med. 359 (2008), 1317–1329.
15. Härtig, W., Reichenbach, A., Voigt, C., Boltze, J., Bulavina, L., Schuhmann, M.U., et al. Triple fluorescence labelling of neuronal, glial and vascular markers revealing pathological alterations in various animal models. J. Chem. Neuroanat. 37 (2009), 128–138.
16. Hawkes, C.A., Michalski, D., Anders, R., Nissel, S., Grosche, J., Bechmann, I., et al. Stroke-induced opposite and age-dependent changes of vessel-associated markers in co-morbid transgenic mice with Alzheimer-like alterations. Exp. Neurol. 250 (2013), 270–281.
17. Hedreen, J.C., Koliatsos, V.E., Phosphorylated neurofilaments in neuronal perikarya and dendrites in human brain following axonal damage. J. Neuropathol. Exp. Neurol. 53 (1994), 663–671.
18. Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., Kohsaka, S., Microglia-specific localisation of a novel calcium binding protein, Iba 1. Mol. Brain Res. 57 (1998), 1–9.
19. Ito, D., Tanaka, K., Suzuki, S., Dembo, T., Fukuuchi, Y., Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32 (2001), 1208–1215.
20. Katchanov, J., Waeber, C., Gertz, K., Gietz, A., Winter, B., Brück, W., et al. Selective neuronal vulnerability following mild focal brain ischemia in the mouse. Brain Pathol. 13 (2003), 452–464.
21. Krueger, M., Härtig, W., Reichenbach, A., Bechmann, I., Michalski, D., Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions. PLoS One, 8, 2013, e56419.
22. Krueger, M., Bechmann, I., Immig, K., Reichenbach, A., Härtig, W., Michalski, D., Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 35 (2015), 292–303.
23. Leifer, D., Kowall, N.W., Immunohistochemical patterns of selective cellular vulnerability in human cerebral ischemia. J. Neurol. Sci. 119 (1993), 217–228.
24. Leterrier, J.F., Käs, J., Hartwig, J., Vegners, R., Janmey, P.A., Mechanical effects of neurofilament cross-bridges. Modulation by phosphorylation, lipids, and interactions with F-actin. J. Biol. Chem. 271 (1996), 15687–15694.
25. Lian, T., Qu, D., Zhao, X., Yu, L., Gao, B., Identification of site-specific stroke biomarker candidates by laser capture microdissection and labeled reference peptide. Int. J. Mol. Sci. 16 (2015), 13427–13441.
26. Longa, E.Z., Weinstein, P.R., Carlson, S., Cummins, R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989), 84–91.
27. Meairs, S., Wahlgren, N., Dirnagl, U., Lindvall, O., Rothwell, P., Baron, J.C., et al. Stroke research priorities for the next decade –a representative view of the European scientific community. Cerebrovasc. Dis. 22 (2006), 75–82.
28. Meller, D., Bellander, B.M., Schmidt-Kastner, R., Ingvar, M., Immunohistochemical studies with antibodies to neurofilament proteins on axonal damage in experimental focal lesions in rat. J. Neurol. Sci. 117 (1993), 164–174.
29. Michalski, D., Grosche, J., Pelz, J., Schneider, D., Weise, C., Bauer, U., et al. A novel quantification of blood-brain barrier damage and histochemical typing after embolic stroke in rats. Brain Res. 1359 (2010), 186–200.
30. Michalski, D., Härtig, W., Krügel, K., Edwards, R.H., Böddener, M., Böhme, L., et al. Region-specific expression of vesicular glutamate and GABA transporters under various ischaemic conditions in mouse forebrain and retina. Neuroscience 231 (2013), 328–344.
31. Michalski, D., Preißler, H., Hofmann, S., Kacza, J., Härtig, W., Decline of microtubule-associated protein tau after experimental stroke in differently aged wild-type and 3xTg mice with Alzheimer-like alterations. Neuroscience 330 (2016), 1–11.
32. Moskowitz, M.A., Lo, E.H., Iadecola, C., The science of stroke: mechanisms in search of treatments. Neuron 67 (2010), 181–198.
33. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
34. Mullen, R.J., Buck, C.R., Smith, A.M., NeuN, a neuronal specific nuclear protein in vertebrates. Development 116 (1992), 201–211.
35. O'Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H., Howells, D.W., 1,026 experimental treatments in acute stroke. Ann. Neurol. 59 (2006), 467–477.
36. Offner, H., Modeling immunity and inflammation in stroke: don't be afraid of mice?. Stroke 45 (2014), e181–e182.
37. Perrot, R., Berges, R., Bocquet, A., Eyer, J., Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol. Neurobiol. 38 (2008), 27–65.
38. Petzold, A., Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci. 233 (2005), 668–678.
39. Popp, A., Jaenisch, N., Witte, O.W., Frahm, C., Identification of ischemic regions in a rat model of stroke. PLoS One, 4, 2009, e4764.
40. Posmantur, R.M., Newcomb, J.K., Kampfl, A., Hayes, R.L., Light and confocal microscopic studies on evolutionary changes in neurofilament proteins following cortical impact injury in rats. Exp. Neurol. 161 (2000), 15–26.
41. Rudrabhatla, P., Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases. J. Alzheimers Dis. 41 (2014), 671–684.
42. Schroeder, E., Vogelgesang, S., Popa-Wagner, A., Kessler, C., Neurofilament expression in the rat brain after cerebral infarction: effect of age. Neurobiol. Aging 24 (2003), 135–145.
43. Schwab, M., Antonow-Schlorke, I., Zwiener, U., Bauer, R., Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats. J. Neural Transm., 1998, 299–311.
44. Ueno, Y., Chopp, M., Zhang, L., Buller, B., Liu, Z., Lehman, N.L., et al. Axonal outgrowth and dendritic plasticity in the cortical peri-infarct area after experimental stroke. Stroke 43 (2012), 2221–2228.
45. Van der Zee, E.A., Naber, P.A., Disterhoft, J.F., Age-dependent changes in the immunoreactivity for neurofilaments in rabbit hippocampus. Neuroscience 79 (1997), 103–116.
46. Young, A.R., Ali, C., Duretête, A., Vivien, D., Neuroprotection and stroke: time for a compromise. J. Neurochem. 103 (2007), 1302–1309.
47. Yuan, A., Rao, M.V., Veeranna, Nixon, R.A., Neurofilaments at a glance. J. Cell Sci. 125 (2012), 3257–3263.
48. Zhang, R.L., Chopp, M., Zhang, Z.G., Jiang, Q., Ewing, J.R., A rat model of focal embolic cerebral ischemia. Brain Res. 766 (1997), 83–92.
49. del Zoppo, G.J., Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 158 (2009), 972–982.
50. del Zoppo, G.J., The neurovascular unit in the setting of stroke. J. Intern. Med. 267 (2010), 156–171.